Gilead is all over the major news already and “US Market Set to Jump on News of Potential Coronavirus Treatment”. This is like watching a good female friend keep going after d-bags who treat her like crap. “But he’s different I swear. Plus he has a camaro!”

Maybe all potential treatments will have a good day as result but I doubt it. I think we take a slight hit. The good news is that if it really does help mild patients and we can stop even a small percentage of cases from becoming severe that’s a good thing and it doesn’t at all diminish how great Leronlimab can still be. Just another hurdle.